Form 4 for AYTU AYTU BIOPHARMA, INC
Accepted 2023-02-10 00:00:00 ET · period of report 2023-02-08 · accession 0001567619-23-002409 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-10 | 2023-02-08 | AYTU | LIU VIVIAN H | Dir | A - Grant | $0.00 | +6,500 | 6,825 | +2,000% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-02-08 | A | A | 6,500 | $0.00 | 6,825 | D | — | — | (F1) Represents restricted share grant. One-third of the restricted shares shall vest on July 1, 2023; the remaining restricted shares shall vest quarterly thereafter, at 1/8th of the remaining grant, with full vesting on July 1, 2025. (F2) Total reflects 1-to-20 reverse stock split effected by the Issuer on January 6, 2023. |